StockData
Integra LifeSciences Holdings Corp logo

Integra LifeSciences Holdings Corp (IART) stock

IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.55−0.43 (-3.08%)

Close on Nov 17, 2026Market cap $1.05BP/E 79.7Yield –

Integra LifeSciences total assets

Total assets on the balance sheet at the end of each period.

Integra LifeSciences's total assets was $3.51B at Sep 30, 2026. For fiscal 2025 it was $3.60B, down 10.8% from the year before. Over ten years it grew 7.3% a year on average. The highest annual figure on record is $4.04B in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.60B-10.8%
FY2024Dec 31, 2024$4.04B+6.8%
FY2023Dec 31, 2023$3.78B-2.8%
FY2022Dec 31, 2022$3.89B+2.8%
FY2021Dec 31, 2021$3.78B+4.6%
FY2020Dec 31, 2020$3.62B+9.4%
FY2019Dec 31, 2019$3.30B+6.3%
FY2018Dec 31, 2018$3.11B-3.2%
FY2017Dec 31, 2017$3.21B+77.6%
FY2016Dec 31, 2016$1.81B+1.9%
FY2015Dec 31, 2015$1.77B+11.8%
FY2014Dec 31, 2014$1.59B+33.2%
FY2013Dec 31, 2013$1.19B+2.5%
FY2012Dec 31, 2012$1.16B+1.7%
FY2011Dec 31, 2011$1.14B+12.3%
FY2010Dec 31, 2010$1.02B+8.4%
FY2009Dec 31, 2009$940.10M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$3.51B-3.8%
Q2 FY2026Jun 30, 2026$3.56B-2.8%
Q1 FY2026Mar 31, 2026$3.58B-11.7%
Q4 FY2025Dec 31, 2025$3.60B-10.8%
Q3 FY2025Sep 30, 2025$3.65B-10.3%
Q2 FY2025Jun 30, 2025$3.67B-10.0%
Q1 FY2025Mar 31, 2025$4.05B-0.6%
Q4 FY2024Dec 31, 2024$4.04B+6.8%
Q3 FY2024Sep 30, 2024$4.07B+8.7%
Q2 FY2024Jun 30, 2024$4.07B+7.9%
Q1 FY2024Mar 31, 2024$4.08B+9.0%
Q4 FY2023Dec 31, 2023$3.78B-2.8%
Q3 FY2023Sep 30, 2023$3.74B-1.8%
Q2 FY2023Jun 30, 2023$3.78B+0.7%
Q1 FY2023Mar 31, 2023$3.74B+1.9%
Q4 FY2022Dec 31, 2022$3.89B+2.8%
Q3 FY2022Sep 30, 2022$3.81B+0.9%
Q2 FY2022Jun 30, 2022$3.75B+1.1%
Q1 FY2022Mar 31, 2022$3.67B-1.9%
Q4 FY2021Dec 31, 2021$3.78B+4.6%
Q3 FY2021Sep 30, 2021$3.77B+9.3%
Q2 FY2021Jun 30, 2021$3.71B+9.5%
Q1 FY2021Mar 31, 2021$3.74B+8.5%
Q4 FY2020Dec 31, 2020$3.62B+9.4%
Q3 FY2020Sep 30, 2020$3.45B+3.2%
Q2 FY2020Jun 30, 2020$3.39B+3.1%
Q1 FY2020Mar 31, 2020$3.45B+7.5%
Q4 FY2019Dec 31, 2019$3.30B+6.3%
Q3 FY2019Sep 30, 2019$3.35B+5.3%
Q2 FY2019Jun 30, 2019$3.29B+3.3%
Q1 FY2019Mar 31, 2019$3.21B-1.3%
Q4 FY2018Dec 31, 2018$3.11B-3.2%
Q3 FY2018Sep 30, 2018$3.18B+31.4%
Q2 FY2018Jun 30, 2018$3.19B+51.6%
Q1 FY2018Mar 31, 2018$3.25B+58.5%
Q4 FY2017Dec 31, 2017$3.21B+77.6%
Q3 FY2017Sep 30, 2017$2.42B–
Q2 FY2017Jun 30, 2017$2.10B–
Q1 FY2017Mar 31, 2017$2.05B–
Q4 FY2016Dec 31, 2016$1.81B–

More Integra LifeSciences figures

See a number that looks wrong?